权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

The role of IWS1 in development and tumorigenesis

IWS1在发育和肿瘤发生中的作用

基本信息

批准号：
8946925
负责人：
Vincenzo Coppola
金额：
$ 54.47万
依托单位：
TUFTS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-07-01 至 2020-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8946925
关键词：
Ablation Address Alternative Splicing Amino Acids Animal Model Animals Binding Biological Biology Breast Adenocarcinoma C-terminal Cell physiology Chromatin Complex DNA Polymerase II Data Databases Development Elongation Factor Embryo Embryonic Development Epigenetic Process Exhibits Gene Targeting Genes Genetic Models Histone H3 Histones Human Human Biology Knock-out Knockout Mice Laboratories Link Malignant Neoplasms Malignant neoplasm of lung Mammalian Cell Mammary gland Mediating Metabolism Molecular Molecular Chaperones Mus Non-Small-Cell Lung Carcinoma Oncogenes Orthologous Gene Phenotype Phosphorylation Physiological Play Process Proteins Publishing RNA RNA Polymerase II RNA Processing RNA Splicing RNA Transport RNA polymerase II largest subunit Reader Reagent Regulation Role Saccharomyces Saccharomyces cerevisiae Signal Transduction Specimen The Cancer Genome Atlas Tissues Transcription Elongation Transferase Tumor Biology Tumor Cell Biology Work Yeasts animal tissue base cancer stem cell chromatin modification epigenetic regulation genome-wide indexing malignant breast neoplasm mature animal melanocyte melanoma member migration mouse model neoplastic cell public health relevance self-renewal tumor tumorigenesis

项目摘要

DESCRIPTION (provided by applicant): Iws1 (Interacts with Spt6) was originally identified in the yeast Saccharomyces Cerevisciae as a binding partner of Spt6, a histone H3/H4 chaperone. Spt6 also binds the C terminal domain (CTD) of the large subunit of RNA Pol II, following the phosphorylation of the latter at Ser2. Recent studies in mammalian cells revealed that the Spt6/Iws1 complex assembled on the CTD of RNA Pol II, contains two additional members, Aly/REF, an adaptor that contributes to nucleocytoplasmic RNA transport, and SetD2, a histone H3K36 trimethyl- transferase. The same studies showed that this complex contributes to alternative RNA splicing. Work in the Tsichlis laboratory extended these observations by showing that the recruitment of SetD2 to the Iws1 complex and the trimethylation of histone H3 at K36 during transcriptional elongation depend on the phosphorylation of Iws1 by Akt1 and Akt3. More important, the Akt-dependent H3K36 trimethylation in transcriptionally active genes regulates alternative RNA splicing and contributes to the biology of human non-small cell lung carcinomas (NSCLCs). More recent studies in the Tsichlis laboratory produced evidence that Iws1 may regulate not only RNA splicing, but also other steps in RNA metabolism. In addition, it may play an important role in the development and biology of tumors other than NSCLCs, including mammary adenocarcinomas and melanomas. It is noteworthy that the role of IWS1 in mammary adenocarcinomas is also supported by large scale data from primary human tumors in the TCGA database. Addressing some of the questions arising from these findings required the establishment of a mouse genetic model. This was accomplished by Dr Coppola who established a conditional Iws1 knockout mouse. Using this mouse, the Tsichlis and Coppola laboratories will address 1) the physiological role of Iws1 in embryonic development and in the biology of adult animal tissues; 2) the role of Iws1 in oncogenesis; and 3) the molecular mechanisms by which Iws1 regulates RNA metabolism and other cellular functions.